Nathan Hardy
2023
In 2023, Nathan Hardy earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer at Sana Biotechnology.
Compensation breakdown
| Non-Equity Incentive Plan | $180,123 |
|---|---|
| Option Awards | $501,923 |
| Salary | $468,921 |
| Stock Awards | $30,800 |
| Other | $4,000 |
| Total | $1,185,767 |
Hardy received $501.9K in option awards, accounting for 42% of the total pay in 2023.
Hardy also received $180.1K in non-equity incentive plan, $468.9K in salary, $30.8K in stock awards and $4K in other compensation.
Rankings
In 2023, Nathan Hardy's compensation ranked 1,023rd out of 2,983 executives tracked by ExecPay. In other words, Hardy earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,023 out of 2,983 | 66th |
Division Manufacturing | 609 out of 1,637 | 63rd |
Major group Chemicals And Allied Products | 418 out of 906 | 54th |
Industry group Drugs | 407 out of 869 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 121 out of 211 | 43rd |
Source: SEC filing on April 26, 2024.
Hardy's colleagues
We found two more compensation records of executives who worked with Nathan Hardy at Sana Biotechnology in 2023.